Malvinder Singh sold out at the right time and at a great valuation.

FORBES: Business Billionaires

With Malvinder now chief executive, company on acquisition binge.

FORBES: Magazine Article

The sudden retirement of Chief Executive Davinder Brar has set off speculation in some corners that Tempest, a nine-year company veteran, is just warming the seat for Malvinder Singh, the founder's grandson.

FORBES: Copycats No More

"The intrinsic India story of fantastic demographics and a growing economy remains intact, " says Malvinder Singh, chairman of Ranbaxy Laboratories, the giant pharmaceutical firm, who argues that the domestic market is big enough to support growth.

FORBES: Mumbai Will Rise Again

Only one fortune from last year's ranks increased, that of brothers Malvinder and Shivinder Singh , who agreed to sell their stake in generic drug firm Ranbaxy Laboratories at a hefty premium to its current stock price.

FORBES: India's 40 Richest

In addition to those cited in this report, the author is particularly grateful for the insights, many of them off the record, of Hal Sirkin, Nandan Nilekani, Alvaro Rodriguez Arragui, Bernard Charles, Joshua Ramo, Michelle Guthrie, Arjun Divecha, Len Blavatnik, Viktor Vekselberg, Malvinder Singh, Bill Ford, Michael Green, Lord John Browne, John Studzinski, Bill Rhodes, Diana Farrell, Mikhail Fridman, Graham Mackey, Thor Bjorgolfsson, Ram Charan, Nabil Habayeb, Diana Glassman, David Rubenstein, Eli Jacobs, Dambisa Moyo, Alastair Newton and Michael Patsalos Fox.

ECONOMIST: Sources and acknowledgments